Book 3, Case 5-Transphenoidal and Acromegaly Flashcards
With patients who have pituitary tumors, what concerns do you have overall?
potential for endocrinologic conditions like Cushings, panhypopituitarism, acromegaly, hyperthyroidism and diabetes insipidus. Procedure related issues like massive hemorrhage, air embolism, cranial nerve damage
Pituitary tumor pt with headache, blurred vision and rhinorrhea-what are you concerned about?
These symptoms are consistent with parasellar extension of the pituitary tumor (at sella-causing headache),compressing the optic chiasm (blurred vision), and inferior
extension of the adenoma (rhinorrhea).
How does a prolactinoma present:
amenorrhea, galactorrhea and infertility
How does cushing’s present:
truncal obesity, abdominal striae, HTN and hyperglycemia
GH tumor presentation:
acromegaly, HTN, insulin resistance, visceromegaly, osteoporosis, skeletal overgrowth
Ant pituitary fxn:
synthesis, storage and growth of the 6 tropic hormones; adrenocorticotrophic hormone.
(ACTH), which stimulates the adrenal cortex secretion; 2) prolactin, which stimulates
the secretion of breast milk and inhibits ovulation; 3) human growth hormone,responsible for body growth; 4) thyroid-stimulating hormone (TSH), which stimulates
thyroid secretion and growth; 5) follicle-stimulating hormone (FSH), responsible for
ovarian follicle growth in females and spermatogenesis in males; and 6) luteinizing
hormone, which stimulates ovulation in females and testosterone secretion in males.
Post pituitary fxn:
(1) antidiuretic hormone (ADH), which promotes water retention and regulates
plasma osmolarity, and (2) oxytocin, which causes uterine contraction and the
ejection of breast milk.
Bromocriptine and Octreotide mechanism:
Bromocriptine is used to treat the excessive excretion of both
prolactin and growth hormone from functional pituitary tumors. It is a synthetic
dopamine-2 receptor agonist that inhibits the secretion of both growth hormone and
prolactin, bringing their levels down sufficiently to improve symptoms in many
patients. Since this patient is also being treated with Octreotide, a drug not often
utilized in the treatment of a functional prolactinoma, I suspect that he is receiving
these medications to treat acromegaly. Octreotide is a somatostatin analogue that
inhibits the release of growth hormone and may actually shrink the size of pituitary
tumors.
Dx of acromegaly is made how?
The diagnosis of acromegaly is based on an initial clinical suspicion,
due to the presence of several characteristic manifestations, and confirmed by
biochemical testing.
The characteristic manifestations of acromegaly include skeletal
overgrowth (large body, hands, and feet; prognathism), soft tissue overgrowth (large
lips, tongue, epiglottis, and vocal cords), recurrent laryngeal nerve paralysis
(secondary to stretching caused by overgrowth of surrounding structures), peripheral
neuropathy (secondary to trapping caused by the overgrowth of surrounding tissue),
visceromegaly, glucose intolerance, osteoarthritis, osteoporosis, hyperhidrosis, and
skeletal muscle weakness. Biochemical tests used to confirm the diagnosis include
measurement of serum IGF-I (the most reliable test since it is less variable throughout
the day),
What general anesthetic concerns would you have in someone with Acromegaly?
My primary concern in patients with acromegaly is the potential for
difficult airway management. Distorted facial anatomy (difficult mask fit),
enlargement of the tongue and epiglottis (predisposition to upper airway obstruction
& impaired visualization during laryngoscopy), overgrowth of the mandible
(prognathism), a narrowed glottis opening (may require smaller endotracheal tube),
enlarged nasal turbinates (may inhibit nasal passage of an airway), and recurrent
laryngeal nerve paralysis may all compromise airway management.
Other than the airway, my concerns would include an increased incidence of coronary
artery disease and the risks associated with hypertension, cardiomegaly, congestive
heart failure, obstructive sleep apnea (mask ventilation, postoperative apnea, and
inadequate pain control), diabetes mellitus, and peripheral neuropathy (positioning).
Would you require an echo prior to starting a case (neuro case in the sitting position?)
Given the increased risk of venous air embolism during intracranial
procedures performed with the head above the level of the heart, I would prefer to
perform a bubble study with precordial echocardiography or transesophageal
echocardiography to rule out a patent foramen ovale, which would place him at risk
for paradoxical embolism to the coronary or cerebral circulations.
Any neuro case-just do a ___
Foley!
A line in acromegaly pts-where?
possibly femoral since pts withacromegaly have poor collateral blood flow to the hand, increasing the
risk of ischemia with partial or complete obstruction of the radial artery.
Visual evoked potentials: when are they used? They are sensitive to what?
Visual evoked potentials (VEPs) are sometimes used to monitor the
integrity of the optic nerves when the surgeon believes they are at significant risk of
surgical trauma during tumor resection. Unfortunately, VEPs are extremely sensitive
to inhalational and intravenous anesthetics, making consistent monitoring very
difficult during general anesthesia. I would use balanced technique withnarcotics and a low concentration of volatile agent to minimize anesthetic
interference with VEP monitoring.
Prior to induction, the surgeon injects the nasal mucosa with cocaine and the
patient suddenly loses consciousness. What do you think is going on? What
would you do?
Therefore, I would: (1) apply
cricoid pressure (risk of aspiration with GERD), (2) intubate the patient (to reduce the
risk of aspiration and control ventilation -7 avoiding hypoxia, hypercapnia, and
acidosis is very important in the setting oflocal anesthetic toxicity), (3) ventilate with
100% oxygen, ( 4) check the EKG and blood pressure, (5) call for a lipid emulsion kit,
and ( 6) administer vasoactive, inotropic and antiarrhythmics agents as indicated. If I
suspected local anesthetic toxicity, I would (7) administer a benzodiazepine (to avoid
seizure-induced patient injury and acidosis), (8) administer small doses of
succinylcholine to treat ongoing tonic-clonic movement (to minimize the hypoxia and
acidosis associated with muscle activity,) and (9) provide hemodynamic support as
required. If the signs and symptoms of local anesthetic toxicity appeared to be
rapidly progressing, the patient experienced prolonged seizure activity, or he
developed signs of cardiac toxicity (i.e. bradycardia, heart block, hypotension,
asystole, or ventricular arrhythmia), I would (10) initiate lipid emulsion therapy and
(11) alert the nearest facility with cardiopulmonary bypass capability.